{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HCV", "medicinal plants", "phytochemicals", "plant-derived molecules"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37439007", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "12"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.7936"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "37", "Issue": "10", "PubDate": {"Year": "2023", "Month": "Oct"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Medicinal plant molecules against hepatitis C virus: Current status and future prospect.", "Pagination": {"StartPage": "4353", "EndPage": "4374", "MedlinePgn": "4353-4374"}, "Abstract": {"AbstractText": ["Hepatitis C virus (HCV), a global malady, causes acute and chronic hepatitis leading to permanent liver damage, hepatocellular carcinoma, and death. Modern anti-HCV therapies are efficient, but mostly inaccessible for residents of underdeveloped regions. To innovate more effective treatments at affordable cost, medicinal plant-based products need to be explored. The aim of this article is to review plant constituents in the light of putative anti-HCV mechanisms of action, and discuss existing problems, challenges, and future directions for their potential application in therapeutic settings. One hundred sixty literatures were collected by using appropriate search strings via scientific search engines: Google Scholar, PubMed, ScienceDirect, and Scopus. Bibliography was prepared using Mendeley desktop software. We found a substantial number of plants that were reported to inhibit different stages of HCV life cycle. Traditional medicinal plants such as Phyllanthus amarus Schumach. and Thonn., Eclipta alba (L.) Hassk., and Acacia nilotica (L.) Delile exhibited strong anti-HCV activities. Again, several phytochemicals such as epigallocatechin-3-gallate, honokilol, punicalagin, and quercetin have shown broad-spectrum anti-HCV effect. We have presented promising phytochemicals like silymarin, curcumin, glycyrrhizin, and camptothecin for nanoparticle-based hepatocyte-targeted drug delivery. Nevertheless, only a few animal studies have been performed to validate the anti-HCV effect of these plant products. Again, insufficient clinical evaluation of the safety and effectiveness of herbal medications remain a problem. Selected plants products could be developed as novel therapeutics for HCV patients only after scrupulous evaluation of their safety and efficacy in a clinical set-up."], "CopyrightInformation": "\u00a9 2023 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0003-3571-2713"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Mrinalini Datta Mahavidyapith, Birati, Kolkata, India."}], "LastName": "Mandal", "ForeName": "Anirban", "Initials": "A"}, {"Identifier": ["0000-0001-7771-3795"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India."}], "LastName": "Hazra", "ForeName": "Banasri", "Initials": "B"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Hepacivirus"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hepatitis C"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Diseases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abenavoli, L., Izzo, A. A., Mili\u0107, N., Cicala, C., Santini, A., & Capasso, R. (2018). Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research, 32(11), 2202-2213. https://doi.org/10.1002/ptr.6171"}, {"Citation": "Adianti, M., Aoki, C., Komoto, M., Deng, L., Shoji, I., Wahyuni, T. S., Lusida, M. I., Soetjipto, Fuchino, H., Kawahara, N., & Hotta, H. (2014). Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species. Microbiology and Immunology, 58(3), 180-187. https://doi.org/10.1111/1348-0421.12127"}, {"Citation": "Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., Lalezari, J., Younes, Z. H., Pockros, P. J., Bisceglie, A. M. D., Arora, S., Subramanian, G. M., Zhu, Y., Sobol, H. D., Yang, J. C., \u2026 ION-2 Investigators. (2014). Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. The New England Journal of Medicine, 370(16), 1483-1493. https://doi.org/10.1056/NEJMoa1316366"}, {"Citation": "Ali, S. I., Sheikh, W. M., Rather, M. A., Venkatesalu, V., Muzamil Bashir, S., & Nabi, S. U. (2021). Medicinal plants: Treasure for antiviral drug discovery. Phytotherapy Research, 35(7), 3447-3483. https://doi.org/10.1002/ptr.7039"}, {"Citation": "Allard, P.-M., Bisson, J., Azzollini, A., Pauli, G. F., Cordell, G. A., & Wolfender, J.-L. (2018). Pharmacognosy in the digital era: Shifting to contextualized metabolomics. Current Opinion in Biotechnology, 54, 57-64. https://doi.org/10.1016/j.copbio.2018.02.010"}, {"Citation": "Anggakusuma, Colpitts, C. C., Schang, L. M., Rachmawati, H., Frentzen, A., Pfaender, S., Behrendt, P., Brown, R. J. P., Bankwitz, D., Steinmann, J., Ott, M., Meuleman, P., Rice, C. M., Ploss, A., Pietschmann, T., & Steinmann, E. (2014). Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut, 63(7), 1137-1149. https://doi.org/10.1136/gutjnl-2012-304299"}, {"Citation": "Aoki, C., Hartati, S., Santi, M. R., Lydwina, Firdaus, R., Hanafi, M., Kardono, B. S. L., Shimizu, Y., Sudarmono, P. P., & Hotta, H. (2014). Isolation and identification of substances with anti-hepatitis c virus activities from kalanchoe pinnata. International Journal of Pharmacy and Pharmaceutical Sciences, 6(2), 211-215."}, {"Citation": "Arca-Lafuente, S., Mart\u00ednez-Rom\u00e1n, P., Mate-Cano, I., Madrid, R., & Briz, V. (2020). Nanotechnology: A reality for diagnosis of HCV infectious disease. The Journal of Infection, 80(1), 8-15. https://doi.org/10.1016/j.jinf.2019.09.010"}, {"Citation": "Ashfaq, U. A., Masoud, M. S., Nawaz, Z., & Riazuddin, S. (2011). Glycyrrhizin as antiviral agent against hepatitis C virus. Journal of Translational Medicine, 9(112), 1-7. https://doi.org/10.1186/1479-5876-9-112"}, {"Citation": "Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., the International Natural Product Sciences Taskforce, & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews. Drug Discovery, 20, 200-216. https://doi.org/10.1038/s41573-020-00114-z"}, {"Citation": "Bachmetov, L., Gal-Tanamy, M., Shapira, A., Vorobeychik, M., Giterman-Galam, T., Sathiyamoorthy, P., Goldhirsh, A. G., Benhar, I., Kaspa, R. T., & Zemel, R. (2012). Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. Journal of Viral Hepatitis, 19, e81-e88. https://doi.org/10.1111/j.1365-2893.2011.01507.x"}, {"Citation": "Bamba, M., Bordage, S., Sahuc, M.-E., Moureu, S., Samaillie, J., Roumy, V., Vauchel, P., Dimitrov, K., Rouill\u00e9, Y., Dubuisson, J., Bi, F. H. T., S\u00e9ron, K., & Sahpaz, S. (2022). Anti-HCV tannins from plants traditionally used in West Africa and extracted with green solvents. Frontiers in Pharmacology, 12, 1-13. https://doi.org/10.3389/fphar.2021.789688"}, {"Citation": "B\u00e1rcena, R., Moreno, A., Rodr\u00edguez-Gand\u00eda, M. A., Albillos, A., Arocena, C., Blesa, C., Hoz, G. F., Graus, J., Nu\u00f1o, J., Herv\u00e1s, P. L., Gajate, L., Mart\u00ednez, A., Bermejo, T., Mateos, M. L., Campo, S. D., & Hospital Ram\u00f3n y Cajal Liver Transplant Group. (2013). Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period. Journal of Hepatology, 58(3), 421-426. https://doi.org/10.1016/j.jhep.2012.10.009"}, {"Citation": "Bell, A. M., Wagner, J. L., Barber, K. E., & Stover, K. R. (2016). Elbasvir/grazoprevir: A review of the latest agent in the fight against hepatitis C. International Journal of Hepatology, 2016, 1-8. https://doi.org/10.1155/2016/3852126"}, {"Citation": "Belperio, P. S., Shahoumian, T. A., Loomis, T. P., & Backus, L. I. (2019). Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients. Journal of Viral Hepatitis, 26(8), 980-990. https://doi.org/10.1111/jvh.13115"}, {"Citation": "Benarba, B., & Pandiella, A. (2020). Medicinal plants as sources of active molecules against COVID-19. Frontiers in Pharmacology, 11(1189), 1-16. https://doi.org/10.3389/fphar.2020.01189"}, {"Citation": "Bhat, R., Adam, A. T., Lee, J. J., Deloison, G., Rouill\u00e9, Y., S\u00e9ron, K., & Rotella, D. P. (2014). Structure-activity studies of (\u2212)-epigallocatechin gallate derivatives as HCV entry inhibitors. Bioorganic and Medicinal Chemistry Letters, 24(17), 4162-4165. https://doi.org/10.1016/j.bmcl.2014.07.051"}, {"Citation": "Blaising, J., L\u00e9vy, P. L., Gondeau, C., Phelip, C., Varbanov, M., Teissier, E., Ruggiero, F., Polyak, S. J., Oberlies, N. H., Ivanovic, T., Boulant, S., & P\u00e9cheur, E. I. (2013). Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cellular Microbiology, 15(11), 1866-1882. https://doi.org/10.1111/cmi.12155"}, {"Citation": "Blazquez, A. G., Fernandez-dolon, M., Sanchez-vicente, L., Maestre, A. D., Miguel, A. B. G., Alvarez, M., Serrano, M. A., Jansen, H., Efferth, T., Marin, J. J. G., & Romero, M. R. (2013). Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis. Bioorganic & Medicinal Chemistry, 21(14), 4432-4441. https://doi.org/10.1016/j.bmc.2013.04.059"}, {"Citation": "Boland, Y., Attout, A., Marchand-Brynaert, J., & Garcia, Y. (2007). Selective thin-layer chromatography of 4-R-1,2,4-triazoles. Journal of Chromatography. A, 1141(1), 145-149. https://doi.org/10.1016/j.chroma.2006.12.012"}, {"Citation": "Bose, M., Kamra, M., Mullick, R., Bhattacharya, S., Das, S., & Karande, A. A. (2017). A plant-derived dehydrorotenoid: A new inhibitor of hepatitis C virus entry. FEBS Letters, 591(9), 1305-1317. https://doi.org/10.1002/1873-3468.12629"}, {"Citation": "Calland, N., Albecka, A., Belouzard, S., Wychowski, C., Duverlie, G., Descamps, V., Hober, D., Jean Dubuisson, J., Rouill\u00e9, Y., & S\u00e9ron, K. (2012). (\u2212)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology, 55(3), 720-729. https://doi.org/10.1002/hep.24803"}, {"Citation": "Calland, N., Sahuc, M.-E., Belouzard, S., P\u00e8ne, V., Bonnafous, P., Mesalam, A. A., Deloison, G., Descamps, V., Sahpaz, S., Wychowski, C., Lambert, O., Brodin, P., Duverlie, G., Meuleman, P., Rosenberg, A. R., Dubuisson, J., Rouill\u00e9, Y., & S\u00e9ron, K. (2015). Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. Journal of Virology, 89(19), 10053-10063. https://doi.org/10.1128/JVI.01473-15"}, {"Citation": "Cao, M.-M., Zhang, Y., Li, X.-H., Peng, Z.-G., Jiang, J.-D., Gu, Y.-C., Di, Y.-T., Li, X.-N., Chen, D.-Z., Xia, C.-F., He, H.-P., Li, S.-L., & Hao, X.-J. (2014). Cyclohexane-fused octahydroquinolizine alkaloids from Myrioneuron faberi with activity against hepatitis C virus. The Journal of Organic Chemistry, 79(17), 7945-7950. https://doi.org/10.1021/jo501076x"}, {"Citation": "Chen, C., Qiu, H., Gong, J., Liu, Q., Xiao, H., Chen, X.-W., Sun, B.-L., & Yang, R.-G. (2012). (\u2212)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Archives of Virology, 157(7), 1301-1312. https://doi.org/10.1007/s00705-012-1304-0"}, {"Citation": "Chen, M. H., Lee, M. Y., Chuang, J. J., Li, Y. Z., Ning, S. T., Chen, J. C., & Liu, Y.-W. (2012). Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International Journal of Molecular Medicine, 30(5), 1021-1028. https://doi.org/10.3892/ijmm.2012.1096"}, {"Citation": "Chen, S. R., Wang, A. Q., Lin, L. G., Qiu, H. C., Wang, Y. T., & Wang, Y. (2016). In vitro study on anti-hepatitis C virus activity of Spatholobus suberectus Dunn. Molecules, 21(10), 1-17. https://doi.org/10.3390/molecules21101367"}, {"Citation": "Chen, W. C., Tseng, C. K., Chen, B. H., Lin, C. K., & Lee, J. C. (2016). Grape seed extract attenuates hepatitis C virus replication and virus-induced inflammation. Frontiers in Pharmacology, 7(490), 1-11. https://doi.org/10.3389/fphar.2016.00490"}, {"Citation": "Chen, W.-C., Wang, S.-Y., Chiu, C.-C., Tseng, C.-K., Lin, C.-K., & Hui-Chun Wang, J.-C. L. (2013). Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction. Antimicrobial Agents and Chemotherapy, 57(3), 1180-1191. https://doi.org/10.1128/AAC.02053-12"}, {"Citation": "Chung, C. Y., Liu, C. H., Burnouf, T., Wang, G. H., Chang, S. P., Jassey, A., Tai, C.-J., Tai, C.-J., Huang, C.-J., Richardson, C. D., Yen, M.-H., Lin, C.-C., & Lin, L.-T. (2016). Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry. Antiviral Research, 130, 58-68. https://doi.org/10.1016/j.antiviral.2016.03.012"}, {"Citation": "Ciesek, S., von Hahn, T., Colpitts, C. C., Schang, L. M., Friesland, M., Steinmann, J., Manns, M. P., Ott, M., Wedemeyer, H., Meuleman, P., Pietschmann, T., & Steinmann, E. (2011). The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology, 54(6), 1947-1955. https://doi.org/10.1002/hep.24610"}, {"Citation": "Cooper, C. L., Druyts, E., Thorlund, K., Nachega, J. B., El Khoury, A. C., O'Regan, C., & Mills, E. J. (2012). Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: An indirect comparison meta-analysis. Therapeutics and Clinical Risk Management, 8, 105-130. https://doi.org/10.2147/TCRM.S29830"}, {"Citation": "Craparo, E. F., Teresi, G., Licciardi, M., Bond\u00ed, M. L., & Cavallaro, G. (2013). Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment. Journal of Biomedical Nanotechnology, 9(6), 1107-1122. https://doi.org/10.1166/jbn.2013.1608"}, {"Citation": "D'Ambrosio, R., Pasulo, L., Puoti, M., Vinci, M., Schiavini, M., Lazzaroni, S., Soria, A., Gatti, F., Menzaghi, B., Aghemo, A., Capelli, F., Rumi, M. G., Morini, L., Giorgini, A., Pigozzi, M. G., Rossini, A., Maggiolo, F., Pan, A., Memoli, M., \u2026 NAVIGATORE-Lombardia Study Group. (2019). Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C. Journal of Hepatology, 70(3), 379-387. https://doi.org/10.1016/j.jhep.2018.11.011"}, {"Citation": "de Avelar, C. R., Pereira, E. M., de Farias Costa, P. R., de Jesus, R. P., & de Oliveira, L. P. M. (2017). Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World Journal of Gastroenterology, 23, 5004-5017. https://doi.org/10.3748/wjg.v23.i27.5004"}, {"Citation": "Deng, G., Kurtz, R. C., Vickers, A., Lau, N., Yeung, K. S., Shia, J., & Cassileth, B. (2011). A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. Journal of Ethnopharmacology, 136(1), 83-87. https://doi.org/10.1016/j.jep.2011.04.008"}, {"Citation": "Dhiman, R. K. (2011). The green tea polyphenol, epigallocatechin-3-gallate (EGCG)-one step forward in antiviral therapy against hepatitis C virus. Journal of Clinical and Experimental Hepatology, 1(3), 159-160. https://doi.org/10.1016/S0973-6883(11)60232-6"}, {"Citation": "Durantel, D. (2009). Celgosivir, an \u03b1-glucosidase I inhibitor for the potential treatment of HCV infection. Current Opinion in Investigational Drugs, 10(8), 860-870."}, {"Citation": "Elberry, M. H., Darwish, N. H. E., & Mousa, S. A. (2017). Hepatitis C virus management: Potential impact of nanotechnology. Virology Journal, 88(2017), 1-10. https://doi.org/10.1186/s12985-017-0753-1"}, {"Citation": "El-Kamary, S. S. (2008). Randomized placebo-controlled trial evaluating the safety and efficacy of silymarin treatment in patients with acute viral hepatitis. Clinical.Trials.gov https://clinicaltrials.gov/ct2/show/NCT00755950"}, {"Citation": "Elsebai, M. F., Koutsoudakis, G., Saludes, V., P\u00e9rez-Vilar\u00f3, G., Turpeinen, A., Mattila, S., Pirttila, A. M., Fontaine-Vive, F., Mehiri, M., Meyerhans, A., & Diez, J. (2016). Pan-genotypic hepatitis C virus inhibition by natural products derived from the wild Egyptian artichoke. Journal of Virology, 90(4), 1918-1930. https://doi.org/10.1128/JVI.02030-15"}, {"Citation": "Ezzikouri, S., Nishimura, T., Kohara, M., Benjelloun, S., Kino, Y., Inoue, K., Matsumori, A., & Tsukiyama-Kohara, K. (2015). Inhibitory effects of Pycnogenol\u00ae on hepatitis C virus replication. Antiviral Research, 113, 93-102. https://doi.org/10.1016/j.antiviral.2014.10.017"}, {"Citation": "Feld, J. J., & Hoofnagle, J. H. (2005). Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature, 436(7053), 967-972. https://doi.org/10.1038/nature04082"}, {"Citation": "Fong, S. Y. K., Wong, Y. C., & Zuo, Z. (2014). Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis, 97, 9-23. https://doi.org/10.1016/j.jpba.2014.03.033"}, {"Citation": "Foster, G. R., Afdhal, N., Roberts, S. K., Br\u00e4u, N., Gane, E. J., Pianko, S., Lawitz, E., Thompson, A., Shiffman, M. L., Cooper, C., Towner, W. J., Conway, B., Ruane, P., Bourli\u00e8re, M., Asselah, T., Berg, T., Zeuzem, S., Rosenberg, W., Agarwal, K., \u2026 ASTRAL-3 Investigators. (2015). Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection. The New England Journal of Medicine, 373(27), 2608-2617. https://doi.org/10.1056/nejmoa1512612"}, {"Citation": "Frank, C., Mohamed, M. K., Strickland, G. T., Lavanchy, D., Arthur, R. R., Magder, L. S., Khoby, T. E., Abdel-Wahab, Y., Ohn, E. S. A., Anwar, W., & Sallam, I. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355(9207), 887-891. https://doi.org/10.1016/S0140-6736(99)06527-7"}, {"Citation": "Fried, M. W., Navarro, V. J., Afdhal, N., Belle, S. H., Wahed, A. S., Hawke, R. L., Doo, E., Meyers, C. M., Reddy, K. R., & Silymarin in NASH and C Hepatitis (SyNCH) Study Group. (2012). Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: A randomized controlled trial. Journal of the American Medical Association, 308(3), 274-282. https://doi.org/10.1001/jama.2012.8265"}, {"Citation": "Gad, H. A., El-Ahmady, S. H., Abou-Shoer, M. I., & Al-Azizi, M. M. (2013). Application of chemometrics in authentication of herbal medicines: A review. Phytochemical Analysis, 24(1), 1-24. https://doi.org/10.1002/pca.2378"}, {"Citation": "Galani, B. R. T., Sahuc, M.-E., Njayou, F. N., Deloison, G., Mkounga, P., Feudjou, W. F., Brodin, P., Rouill\u00e9, Y., Nkengfack, A. E., Moundipa, P. F., & S\u00e9ron, K. (2015). Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. Frontiers in Microbiology, 6(488), 1-9. https://doi.org/10.3389/fmicb.2015.00488"}, {"Citation": "Galani, B. R. T., Sahuc, M. E., Sass, G., Njayou, F. N., Loscher, C., Mkounga, P., Gaspard Deloison, G., Brodin, P., Rouill\u00e9, Y., Tiegs, G., S\u00e9ron, K., & Moundipa, P. F. (2016). Khaya grandifoliola C.DC: A potential source of active ingredients against hepatitis C virus in vitro. Archives of Virology, 161(5), 1169-1181. https://doi.org/10.1007/s00705-016-2771-5"}, {"Citation": "Galani Tietcheu, B. R., Sass, G., Njayou, N. F., Mkounga, P., Tiegs, G., & Moundipa, P. F. (2014). Anti-hepatitis C virus activity of crude extract and fractions of Entada africana in genotype 1b replicon systems. The American Journal of Chinese Medicine, 42(4), 853-868. https://doi.org/10.1142/S0192415X14500542"}, {"Citation": "Geddawy, A., Ibrahim, Y. F., Elbahie, N. M., & Ibrahim, M. A. (2017). Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction. Journal of Translational Internal Medicine, 5(1), 8-17. https://doi.org/10.1515/jtim-2017-0007"}, {"Citation": "Ghany, M. G., Lok, A. S. F., Dienstag, J. L., Feinstone, S. M., Hoofnagle, J. H., Liang, J. T., Seeff, L. B., Cohen, D. E., Bezerra, J. A., & Chung, R. T. (2021). The 2020 Nobel prize for medicine or physiology for the discovery of hepatitis C virus: A triumph of curiosity and persistence. Hepatology, 74(5), 2813-2823. https://doi.org/10.1002/hep.31830"}, {"Citation": "Ghosh, S., Sarma, M. D., & Hazra, B. (2010). HPLC of quinones. In M. Waksmundzka-Hajnos & J. Sherma (Eds.), High performance liquid chromatography in phytochemical analysis, Chapter 34 (pp. 909-937). CRC Press/Taylor & Francis Group."}, {"Citation": "Goldwasser, J., Cohen, P. Y., Lin, W., Kitsberg, D., Balaguer, P., Polyak, S. J., Chung, R. T., Yarmush, M. L., & Nahmias, Y. (2011). Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. Journal of Hepatology, 55(5), 963-971. https://doi.org/10.1016/j.jhep.2011.02.011"}, {"Citation": "Gonzalez, O., Fontanes, V., Raychaudhuri, S., Loo, R., Loo, J., Arumugaswami, V., Sun, R., Dasgupta, A., & French, S. W. (2009). The heat shock protein inhibitor quercetin attenuates hepatitis C virus production. Hepatology, 50(6), 1756-1764. https://doi.org/10.1002/hep.23232"}, {"Citation": "Gordon, A., Hobbs, D. A., Bowden, D. S., Bailey, M. J., Mitchell, J., Francis, A. J. P., & Roberts, S. K. (2006). Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology, 21(1 Pt 2), 275-280. https://doi.org/10.1111/j.1440-1746.2006.04138.x"}, {"Citation": "Gritsenko, D., & Hughes, G. (2015). Ledipasvir/Sofosbuvir (harvoni): Improving options for hepatitis C virus infection. Pharmacology & Therapeutics, 40(4), 256-276."}, {"Citation": "Hafid, A. F., Aoki-Utsubo, C., Permanasari, A. A., Adianti, M., Tumewu, L., Widyawaruyanti, A., Wahyuningsih, S. P. A., Wahyuni, T. S., Lusida, M. L., Soetjipto, & Hotta, H. (2017). Antiviral activity of the dichloromethane extracts from Artocarpus heterophyllus leaves against hepatitis C virus. Asian Pacific Journal of Tropical Biomedicine, 7(7), 633-639. https://doi.org/10.1016/j.apjtb.2017.06.003"}, {"Citation": "Haid, S., Novodomsk\u00e1, A., Gentzsch, J., Grethe, C., Geuenich, S., Bankwitz, D., Chhatwal, P., Jannack, B., Hennebelle, T., Bailleul, F., Keppler, O. T., Poenisch, M., Bartenschlager, R., Hernandez, C., Lemasson, M., Rosenberg, A. R., Wong-Staal, F., Davioud-Charvet, E., & Pietschmann, T. (2012). A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology, 143(1), 213-222. https://doi.org/10.1053/j.gastro.2012.03.036"}, {"Citation": "Hassan, S. T. S., Berchov\u00e1-B\u00edmov\u00e1, K., & Petr\u00e1\u0161, J. (2016). Plumbagin, a plant-derived compound, exhibits antifungal combinatory effect with amphotericin B against Candida albicans clinical isolates and anti-hepatitis C virus activity. Phytotherapy Research, 30(9), 1487-1492. https://doi.org/10.1002/ptr.5650"}, {"Citation": "Hawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., Berman, J., Liu, Q.-Y., Doo, E., Fried, M. W., & SyNCH Trial Group. (2010). Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. Journal of Clinical Pharmacology, 50(4), 434-449. https://doi.org/10.1177/0091270009347475"}, {"Citation": "Hazra, B., Sarma, M. D., & Sanyal, U. (2004). Separation methods of quinonoid constituents of plants used in oriental traditional medicines. Journal of Chromatography B, 812(1-2), 259-275. https://doi.org/10.1016/j.jchromb.2004.08.007"}, {"Citation": "Hekmat, S., Aslani, M. M., Ardestani, S. M., Aghasadeghi, M. R., Siadat, S. D., Sadat, S. M., Mahdavi, M., Shahbazi, S., Asgarhalvaee, F., Ghahari, S. M. M., & Tohidi, F. (2017). Preparation and characterization of PLGA nanoparticles containing recombinant core-NS3 fusion protein of hepatitis C virus as a nano-vaccine candidate. Vaccine Research, 4(1), 13-18."}, {"Citation": "Hernandez, M. D., & Sherman, K. E. (2011). HIV/HCV coinfection natural history and disease progression, a review of the most recent literature. Current Opinion in HIV and AIDS, 6(6), 478-482. https://doi.org/10.1097/COH.0b013e32834bd365"}, {"Citation": "Hsu, W. C., Chang, S. P., Lin, L. C., Li, C. L., Richardson, C. D., Lin, C. C., & Lin, L. T. (2015). Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry. Antiviral Research, 118, 139-147. https://doi.org/10.1016/j.antiviral.2015.04.003"}, {"Citation": "Huang, S. D., Zhang, Y., Cao, M. M., Di, Y. T., Tang, G. H., Peng, Z. G., Jiang, J. D., He, H.-P., & Hao, X.-J. (2013). Myriberine A, a new alkaloid with an unprecedented heteropentacyclic skeleton from Myrioneuron faberi. Organic Letters, 15(3), 590-593. https://doi.org/10.1021/ol3034065"}, {"Citation": "Ishihara, T., Kaneko, K., Ishihara, T., & Mizushima, T. (2014). Development of biodegradable nanoparticles for liver-specific ribavirin delivery. Journal of Pharmaceutical Sciences, 103(12), 4005-4011. https://doi.org/10.1002/jps.24219"}, {"Citation": "Izzo, A. A., Hoon-Kim, S., Radhakrishnan, R., & Williamson, E. M. (2016). A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytotherapy Research, 30(5), 691-700. https://doi.org/10.1002/ptr.5591"}, {"Citation": "Jardim, A. C. G., Igloi, Z., Shimizu, J. F., Santos, V. A. F. F. M., Felippe, L. G., Mazzeu, B. F., Furlan, M., Harris, M., & Rahal, P. (2015). Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro. Antiviral Research, 115, 39-47. https://doi.org/10.1016/j.antiviral.2014.12.018"}, {"Citation": "Jassim, S. A. A., & Naji, M. A. (2003). Novel antiviral agents: A medicinal plant perspective. Journal of Applied Microbiology, 95, 412-427. https://doi.org/10.1046/j.1365-2672.2003.02026.x"}, {"Citation": "Javed, T., Ashfaq, U. A., Riaz, S., Rehman, S., & Riazuddin, S. (2011). In-vitro antiviral activity of Solanum nigrum against hepatitis C virus. Virology Journal, 8(26), 1-7. https://doi.org/10.1186/1743-422X-8-26"}, {"Citation": "Jimenez-Aleman, G. H., Castro, V., Londaitsbehere, A., Gutierrez-Rodr\u00edguez, M., Garaigorta, U., Solano, R., & Gastaminza, P. (2021). SARS-CoV-2 fears green: The chlorophyll catabolite pheophorbide a is a potent antiviral. Pharmaceuticals, 14(10), 1-19. https://doi.org/10.3390/ph14101048"}, {"Citation": "Jim\u00e9nez-Pardo, I., Gonz\u00e1lez-Pastor, R., Lancelot, A., Claveria-Gimeno, R., Vel\u00e1zquez-Campoy, A., Abian, O., Ros, M. B., & Sierra, T. (2015). Shell cross-linked polymeric micelles as camptothecin nanocarriers for anti-HCV therapy. Macromolecular Bioscience, 15(10), 1381-1391. https://doi.org/10.1002/mabi.201500094"}, {"Citation": "Kadioglu, O., Saeed, M., Greten, H. J., & Efferth, T. (2021). Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Computers in Biology and Medicine, 133, 104359. https://doi.org/10.1016/j.compbiomed.2021.104359"}, {"Citation": "Kaushik-Basu, N., Bopda-Waffo, A., Talele, T. T., Basu, A., Costa, P. R. R., Da Silva, A. J. M., Sarafianos, S. G., & Noel, F. (2008). Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors. Nucleic Acids Research, 36, 1482-1496. https://doi.org/10.1093/nar/gkm1178"}, {"Citation": "Khachatoorian, R., Arumugaswami, V., Raychaudhuri, S., Yeh, G. K., Maloney, E. M., Wang, J., Dasgupta, A., & French, S. W. (2012). Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle. Virology, 433(2), 346-355. https://doi.org/10.1016/j.virol.2012.08.029"}, {"Citation": "Kim, J. W., Park, S. J., Lim, J. H., Yang, J. W., Shin, J. C., Lee, S. W., Suh, J. W., & Hwang, S. B. (2013). Triterpenoid saponins isolated from Platycodon grandiflorum inhibit hepatitis C virus replication. Evidence-Based Complementary and Alternative Medicine, 2013, 1-11. https://doi.org/10.1155/2013/560417"}, {"Citation": "Kim, K., Kim, K. H., Kim, H. Y., Cho, H. K., Sakamoto, N., & Cheong, J. (2010). Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Letters, 584(4), 707-712. https://doi.org/10.1016/j.febslet.2009.12.019"}, {"Citation": "Kim, W. T., Lim, J. L., Ong, I. S., Ark, S. P., & Ang, J. Y. (2012). Hepatoprotective and anti-hepatitis C viral activity of Platycodon grandiflorum extract on carbon tetrachloride-induced acute hepatic injury in mice. Journal of Nutritional Science and Vitaminology (Tokyo), 58(3), 187-194. https://doi.org/10.3177/jnsv.58.187"}, {"Citation": "Koga, K., Nishimon, Y., Ueta, H., Matsuno, K., & Takada, K. (2011). Utility of nano-sized, water-in-oil emulsion as a sustained release formulation of glycyrrhizin. Biological & Pharmaceutical Bulletin, 34(2), 300-305. https://doi.org/10.1248/bpb.34.300"}, {"Citation": "Lan, K.-H., Wang, Y.-W., Lee, W.-P., Lan, K.-L., Tseng, S.-H., Hung, L.-R., Yen, S. H., Lin, H. C., & Lee, S.-D. (2012). Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver International, 32(6), 989-997. https://doi.org/10.1111/j.1478-3231.2011.02621.x"}, {"Citation": "Lancelot, A., Claver\u00eda-Gimeno, R., Vel\u00e1zquez-Campoy, A., Abian, O., Serrano, J. L., & Sierra, T. (2017). Nanostructures based on ammonium-terminated amphiphilic Janus dendrimers as camptothecin carriers with antiviral activity. European Polymer Journal, 90, 136-149. https://doi.org/10.1016/j.eurpolymj.2017.03.012"}, {"Citation": "Lee, H. Y., Yum, J. H., Rho, Y. K., Oh, S. J., Choi, H. S., Chang, H. B., Choi, D. H., Leem, M.-J., Choi, E. J., Ryu, J. M., & Hwang, S. B. (2007). Inhibition of HCV replicon cell growth by 2-arylbenzofuran derivatives isolated from Mori Cortex Radicis. Planta Medica, 73(14), 1481-1485. https://doi.org/10.1055/s-2007-990249"}, {"Citation": "Lee, J. C., Chen, W. C., Wu, S. F., Tseng, C. K., Chiou, C. Y., Chang, F. R., Hsu, S. H., & Wu, Y.-C. (2011). Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. Antiviral Research, 89(1), 35-42. https://doi.org/10.1016/j.antiviral.2010.11.003"}, {"Citation": "Lee, J. C., Tseng, C. K., Young, K. C., Sun, H. Y., Wang, S. W., Chen, W. C., Lin, C.-K., & Wu, Y.-H. (2014). Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. British Journal of Pharmacology, 171(1), 237-252. https://doi.org/10.1111/bph.12440"}, {"Citation": "Lee, S., Yoon, K. D., Lee, M., Cho, Y., Choi, G., Jang, H., Kim, B., Jung, D.-H., Oh, J.-G., Kim, G.-W., Oh, J.-W., Jeong, Y.-J., Kwon, H. J., Bae, S. K., Min, D.-H., Windisch, M. P., Heo, T.-H., & Lee, C. (2016). Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase. British Journal of Pharmacology, 173(1), 191-211. https://doi.org/10.1111/bph.13358"}, {"Citation": "Li, S., Kodama, E. N., Inoue, Y., Tani, H., Matsuura, Y., & Zhang, J. (2010). Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. Antiviral Chemistry and Chemotherapy, 20(6), 239-248. https://doi.org/10.3851/IMP1597"}, {"Citation": "Lin, C. W., Lo, C. W., Tsai, C. N., Pan, T. C., Chen, P. Y., & Yu, M. J. (2018). Aeginetia indica decoction inhibits hepatitis C virus life cycle. International Journal of Molecular Sciences, 19(1), 1-12. https://doi.org/10.3390/ijms19010208"}, {"Citation": "Lin, L. T., Chung, C. Y., Hsu, W. C., Chang, S. P., Hung, T. C., Shields, J., Russell, R. S., Lin, C.-C., Li, C.-F., Yen, M.-H., Tyrrell, D. L. J., Lin, C.-C., & Richardson, C. D. (2015). Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Journal of Hepatology, 62(3), 541-548. https://doi.org/10.1016/j.jhep.2014.10.040"}, {"Citation": "Liu, C. H., Jassey, A., Hsu, H. A., & Lin, L. T. (2019). Antiviral activities of silymarin and derivatives. Molecules, 24(1552), 1-15. https://doi.org/10.3390/molecules24081552"}, {"Citation": "Liu, C. H., Lin, C. C., Hsu, W. C., Chung, C. Y., Lin, C. C., Jassey, A., Chang, S. P., Tai, C.-J., Tai, C.-J., Shields, J., Richardson, C. D., Yen, M.-H., Tyrrell, D. L. J., & Lin, L.-T. (2017). Highly bioavailable silibinin nanoparticles inhibit HCV infection. Gut, 66(10), 1853-1861. https://doi.org/10.1136/gutjnl-2016-312019"}, {"Citation": "Liu, G., Dong, J., Wang, H., Hashi, Y., & Chen, S. (2011). Characterization of alkaloids in Sophora flavescens Ait. by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 54(5), 1065-1072. https://doi.org/10.1016/j.jpba.2010.12.024"}, {"Citation": "Ma, J. N., Bolraa, S., Ji, M., He, Q. Q., & Ma, C. M. (2015). Quantification and antioxidant and anti-HCV activities of the constituents from the inflorescences of Scabiosa comosa and S. tschilliensis. Natural Product Research, 30(5), 1-5. https://doi.org/10.1080/14786419.2015.1027701"}, {"Citation": "Mandal, A., Biswas, D., & Hazra, B. (2020). Natural products from plants with prospective anti-HIV activity and relevant mechanisms of action. In Studies in natural products chemistry.Chapter 9 (Vol. 66, pp. 225-271). Elsevier. https://doi.org/10.1016/B978-0-12-817907-9.00009-X"}, {"Citation": "Mandal, A., Hazra, B., Prajapati, V. K., & Moundipa, P. F. (2022). Plant products for antiviral therapeutics. Frontiers in Pharmacology, 13, 1-4. https://doi.org/10.3389/fphar.2022.1039183"}, {"Citation": "Mandal, A., Jha, A. K., & Hazra, B. (2021). Plant products as inhibitors of coronavirus 3CL protease. Frontiers in Pharmacology, 12, 1-16. https://doi.org/10.3389/fphar.2021.583387"}, {"Citation": "Manvar, D., Mishra, M., Kumar, S., & Pandey, V. N. (2012). Identification and evaluation of anti-hepatitis C virus phytochemicals from Eclipta alba. Journal of Ethnopharmacology, 144, 545-554. https://doi.org/10.1016/j.jep.2012.09.036"}, {"Citation": "Mari\u00f1o, Z., Crespo, G., D'Amato, M., Brambilla, N., Giacovelli, G., Rovati, L., Costa, J., Navasa, M., & Forns, X. (2013). Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period. Journal of Hepatology, 58(3), 415-420. https://doi.org/10.1016/j.jhep.2012.09.034"}, {"Citation": "Matsumoto, Y., Matsuura, T., Aoyagi, H., Matsuda, M., Hmwe, S. S., Date, T., Watanabe, N., Watashi, K., Suzuki, R., Ichinose, S., Wake, K., Suzuki, T., Miyamura, T., Wakita, T., & Aizaki, H. (2013). Antiviral activity of glycyrrhizin against hepatitis C virus in vitro. PLoS One, 8(7), 1-10. https://doi.org/10.1371/journal.pone.0068992"}, {"Citation": "Meewan, I., Zhang, X., Roy, S., Ballatore, C., O'Donoghue, A. J., Schooley, R. T., & Abagyan, R. (2019). Discovery of new inhibitors of hepatitis C virus NS3/4A protease and its D168A mutant. ACS Omega, 4(16), 16999-17008. https://doi.org/10.1021/acsomega.9b02491"}, {"Citation": "Meuleman, P., Albecka, A., Belouzard, S., Vercauteren, K., Verhoye, L., Wychowski, C., Leroux-Roels, G., Palmer, K. E., & Dubuisson, J. (2011). Griffithsin has antiviral activity against hepatitis C virus. Antimicrobial Agents and Chemotherapy, 55(11), 5159-5167. https://doi.org/10.1128/AAC.00633-11"}, {"Citation": "Milosevi\u0107, N., Milanovi\u0107, M., Abenavoli, L., & Milic, N. (2014). Phytotherapy and NAFLD-From goals and challenges to clinical practice. Reviews on Recent Clinical Trials, 9(3), 195-203."}, {"Citation": "Mishra, B. B., & Tiwari, V. K. (2011). Natural products: An evolving role in future drug discovery. European Journal of Medicinal Chemistry, 46(10), 4769-4807. https://doi.org/10.1016/j.ejmech.2011.07.057"}, {"Citation": "Mishra, D., Jain, N., Rajoriya, V., & Jain, A. K. (2014). Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. The Journal of Pharmacy and Pharmacology, 66(8), 1082-1093. https://doi.org/10.1111/jphp.12235"}, {"Citation": "Moradpour, D., Penin, F., & Rice, C. M. (2007). Replication of hepatitis C virus. Nature Reviews. Microbiology, 5, 453-463. https://doi.org/10.1038/nrmicro1645"}, {"Citation": "Musarra-Pizzo, M., Pennisi, R., Ben-Amor, I., Mandalari, G., & Sciortino, M. T. (2021). Antiviral activity exerted by natural products against human viruses. Viruses, 13(5), 1-30. https://doi.org/10.3390/v13050828"}, {"Citation": "Mustafa, A. M., Angeloni, S., Abouelenein, D., Acquaticci, L., Xiao, J., Sagratini, G., Maggi, F., Vittori, S., & Caprioli, G. (2022). A new HPLC-MS/MS method for the simultaneous determination of 36 polyphenols in blueberry, strawberry and their commercial products and determination of antioxidant activity. Food Chemistry, 367(2022), 130743. https://doi.org/10.1016/j.foodchem.2021.130743"}, {"Citation": "Nahmias, Y., Goldwasser, J., Casali, M., Van Poll, D., Wakita, T., Chung, R. T., & Yarmush, M. L. (2008). Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology, 47(5), 1437-1445. https://doi.org/10.1002/hep.22197"}, {"Citation": "Newman, D. J., & Cragg, G. M. (2020). Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770-803. https://doi.org/10.1021/acs.jnatprod.9b01285"}, {"Citation": "Nichols, D. B., Le\u00e3o, R. A. C., Basu, A., Chudayeu, M., de Moraes, P. D. F., Talele, T. T., Costa, P. R. R., & Kaushik-Basu, N. (2013). Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors. Chemical Biology & Drug Design, 81(5), 607-614. https://doi.org/10.1111/cbdd.12105"}, {"Citation": "Noreen, S., Hussain, I., Tariq, M. I., Ijaz, B., Iqbal, S., Qamar-Ul-Zaman, Ashfaq, U. A., & Husnain, T. (2015). Portulaca oleracea L. as a prospective candidate inhibitor of hepatitis C virus NS3 serine protease. Viral Immunology, 28(5), 282-289. https://doi.org/10.1089/vim.2014.0079"}, {"Citation": "Obeid, S., Alen, J., Nguyen, V. H., Pham, V. C., Meuleman, P., Pannecouque, C., Le, T. N., Neyts, J., Dehaen, W., & Paeshuyse, J. (2013). Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication. PLoS One, 8(12), 1-6. https://doi.org/10.1371/journal.pone.0081783"}, {"Citation": "Paeshuyse, J., Coelmont, L., Vliegen, I., Hemel, J. V., Vandenkerckhove, J., Peys, E., Sas, B., Clercq, E. D., & Neyts, J. (2006). Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin. Biochemical and Biophysical Research Communications, 348(1), 139-144. https://doi.org/10.1016/j.bbrc.2006.07.014"}, {"Citation": "Palumbo, E. (2011). Pegylated interferon and ribavirin treatment for hepatitis C virus infection. Clinical Medicine Insights: Therapeutics, 3, 137-150. https://doi.org/10.1177/2040622310384308"}, {"Citation": "Pisonero-Vaquero, S., Garc\u00eda-Mediavilla, M. V., Jorquera, F., Majano, P. L., Benet, M., Jover, R., Gonz\u00e1lez-Gallego, J., & S\u00e1nchez-Campos, S. (2014). Modulation of PI3K-LXR\u03b1-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin. Laboratory Investigation, 94, 262-274. https://doi.org/10.1038/labinvest.2013.156"}, {"Citation": "Polyak, S. J., Ferenci, P., & Pawlotsky, J. M. (2013). Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology, 57(3), 1262-1271. https://doi.org/10.1002/hep.26179"}, {"Citation": "Polyak, S. J., Morishima, C., Lohmann, V., Pal, S., Lee, D. Y. W., Liu, Y., Graf, T. N., & Oberlies, N. H. (2010). Identification of hepatoprotective flavonolignans from silymarin. Proceedings of the National Academy of Sciences of the United States of America, 107(13), 5995-5999. https://doi.org/10.1073/pnas.0914009107"}, {"Citation": "Polyak, S. J., Oberlies, N. H., P\u00e9cheur, E. I., Dahari, H., Ferenci, P., & Pawlotsky, J. M. (2013). Silymarin for HCV infection. Antiviral Therapy, 18(2), 141-147. https://doi.org/10.3851/IMP2402"}, {"Citation": "Poordad, F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M. S., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., DiNubile, M. J., Sniukiene, V., Brass, C. A., Albrecht, J. K., Bronowicki, J.-P., & SPRINT-2 Investigators. (2011). Boceprevir for untreated chronic HCV genotype 1 infection. The New England Journal of Medicine, 364(13), 1195-1206. https://doi.org/10.1056/NEJMoa1010494"}, {"Citation": "Pour, P. M., Fakhri, S., Asgary, S., Farzaei, M. H., & Echeverr\u00eda, J. (2019). The signaling pathways, and therapeutic targets of antiviral agents: Focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral diseases. Frontiers in Pharmacology, 10, 1-23. https://doi.org/10.3389/fphar.2019.01207"}, {"Citation": "Rashed, K., Sahuc, M. E., Deloison, G., Calland, N., Brodin, P., Rouill\u00e9, Y., & S\u00e9ron, K. (2014). Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro. Journal of Functional Foods, 11, 185-191. https://doi.org/10.1016/j.jff.2014.09.022"}, {"Citation": "Ravikumar, Y. S., Ray, U., Nandhitha, M., Perween, A., Raja Naika, H., Khanna, N., & Das, S. (2011). Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Research, 158(1-2), 89-97. https://doi.org/10.1016/j.virusres.2011.03.014"}, {"Citation": "Reddy, B. U., Mullick, R., Kumar, A., Sudha, G., Srinivasan, N., & Das, S. (2014). Small molecule inhibitors of HCV replication from pomegranate. Scientific Reports, 4, 1-10. https://doi.org/10.1038/srep05411"}, {"Citation": "Reddy, K. R., Belle, S. H., Fried, M. W., Afdhal, N., Navarro, V. J., Hawke, R. L., Wahed, A. S., Doo, E., Meyers, C. M., & SyNCH Study Group. (2012). Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C. Clinical Trials, 9(1), 102-112. https://doi.org/10.1177/1740774511427064"}, {"Citation": "Rehman, S., Ashfaq, U. A., Riaz, S., Javed, T., & Riazuddin, S. (2011). Antiviral activity of Acacia nilotica against hepatitis C virus in liver infected cells. Virology Journal, 8(220), 1-6. https://doi.org/10.1186/1743-422X-8-220"}, {"Citation": "Rendina, M., D'Amato, M., Castellaneta, A., Castellaneta, N. M., Brambilla, N., Giacovelli, G., Rovati, L., Rizzi, S. F., Zappimbulso, M., Bringiotti, R. S., & Leo, A. D. (2014). Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: A randomized clinical trial. Transplant International, 27(7), 696-704. https://doi.org/10.1111/tri.12324"}, {"Citation": "Ripoli, M., Angelico, R., Sacco, P., Ceglie, A., & Mangia, A. (2016). Phytoliposome-based silibinin delivery system as a promising strategy to prevent hepatitis C virus infection. Journal of Biomedical Nanotechnology, 12(4), 770-780. https://doi.org/10.1166/jbn.2016.2161"}, {"Citation": "Rivero-Buceta, E., Carrero, P., Doyag\u00fcez, E. G., Madrona, A., Quesada, E., Camarasa, M. J., Per\u00e9z-P\u00e9rez, M. J., Leyssen, P., Paeshuyse, J., Balzarini, J., Neyts, J., & San-F\u00e9lix, A. (2015). Linear and branched alkyl-esters and amides of gallic acid and other (mono-, di- and tri-) hydroxy benzoyl derivatives as promising anti-HCV inhibitors. European Journal of Medicinal Chemistry, 6(92), 656-671. https://doi.org/10.1016/j.ejmech.2015.01.033"}, {"Citation": "Rojas, N., Del Campo, J. A., Clement, S., Lemasson, M., Garc\u00eda-Valdecasas, M., Gil-G\u00f3mez, A., Ranchal, I., Bartosch, B., Bautista, J. D., Rosenberg, A. R., Negro, F., & Romero-G\u00f3meza, M. (2016). Effect of quercetin on Hepatitis C virus life cycle: From viral to host targets. Scientific Reports, 6, 1-9. https://doi.org/10.1038/srep31777"}, {"Citation": "Rottapharm. (2012). Effect of LEGALON SIL on hepatitis C virus recurrence in stable liver transplanted patients (LEG-SIL-LTX-02). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01518933"}, {"Citation": "Sahuc, M.-E., Sahli, R., Rivi\u00e8re, C., P\u00e8ne, V., Lavie, M., Vandeputte, A., Brodin, P., Rosenberg, A. R., Dubuisson, J., Ksouri, R., Rouill\u00e9, Y., Sahpaz, S., & S\u00e9ron, K. (2019). Dehydrojuncusol, a natural phenanthrene compound extracted from Juncus maritimus, is a new inhibitor of hepatitis C virus RNA replication. Journal of Virology, 93(10), 1-15."}, {"Citation": "Sajitha Lulu, S., Thabitha, A., Vino, S., Mohana Priya, A., & Rout, M. (2016). Naringenin and quercetin-Potential anti-HCV agents for NS2 protease targets. Natural Product Research, 30(4), 464-468. https://doi.org/10.1080/14786419.2015.1020490"}, {"Citation": "Seeff, L. B., Curto, T. M., Szabo, G., Everson, G. T., Bonkovsky, H. L., Dienstag, J. L., Shiffman, M. L., Lindsay, K. L., Lok, A. S. F., Bisceglie, A. M. D., Lee, W. M., Ghany, M. G., & HALT-C Trial Group. (2008). Herbal product use by persons enrolled in the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology, 47(2), 605-612. https://doi.org/10.1002/hep.22044"}, {"Citation": "Sharaf, M., Nehal, M., & El-Deeb, H. I. E.-A. (2012). The potentiality og grape seed extract as a novel anti-hepatitis C virus agent. Journal of Medical Sciences, 12(4), 107-113."}, {"Citation": "Spann, N. J., Kang, S., Li, A. C., Chen, A. Z., Newberry, E. P., Davidson, N. O., Hui, S. T. Y., & Davis, R. A. (2006). Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. The Journal of Biological Chemistry, 281(44), 33066-33077. https://doi.org/10.1074/jbc.M607148200"}, {"Citation": "Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., Abu-Raddad, L. J., Assadi, R., Bhala, N., Cowie, B., Forouzanfour, M. H., Groeger, J., Hanafiah, K. M., Jacobsen, K. H., James, S. L., MacLachlan, J., Malekzadeh, R., Martin, N. K., Mokdad, A. A., \u2026 Cooke, G. S. (2016). The global burden of viral hepatitis from 1990 to 2013: Findings from the global burden of disease study 2013. Lancet, 388(10049), 1081-1088. https://doi.org/10.1016/S0140-6736(16)30579-7"}, {"Citation": "Susiloningrum, D., Permanasari, A. A., Adianti, M., Tumewu, L., Wahyuni, T. S., Tanjung, M., Widyawaruyanti, A., & Hafid, A. F. (2020). The alkaloid fraction from Melicope latifolia leaves inhibits hepatitis C virus. Pharmacognosy Journal, 12(3), 535-540. https://doi.org/10.5530/pj.2020.12.81"}, {"Citation": "Takebe, Y., Saucedo, C. J., Lund, G., Uenishi, R., Hase, S., Tsuchiura, T., Kneteman, N., Ramessar, K., Tyrrell, D. L. J., Shirakura, M., Wakita, T., McMahon, J. B., & O'Keefe, B. R. (2013). Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus. PLoS One, 8(5), 1-10. https://doi.org/10.1371/journal.pone.0064449"}, {"Citation": "Takeshita, M., Ishida, Y. I., Akamatsu, E., Ohmori, Y., Sudoh, M., Oto, H., Tsubouchi, H., & Kataoka, H. (2009). Proanthocyanidin from Blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA. The Journal of Biological Chemistry, 284(32), 21165-21176. https://doi.org/10.1074/jbc.M109.004945"}, {"Citation": "Tamura, S., Yang, G. M., Yasueda, N., Matsuura, Y., Komoda, Y., & Murakami, N. (2010). Tellimagrandin I, HCV invasion inhibitor from Rosae Rugosae Flos. Bioorganic and Medicinal Chemistry Letters, 20(5), 1598-1600. https://doi.org/10.1016/j.bmcl.2010.01.084"}, {"Citation": "Thomas, T., & Foster, G. (2007). Nanomedicines in the treatment of chronic hepatitis C-Focus on pegylated interferon alpha-2a. International Journal of Nanomedicine, 2(1), 19-24. https://doi.org/10.2147/nano.2007.2.1.19"}, {"Citation": "Tietjen, I., Ntie-Kang, F., Mwimanzi, P., Ongu\u00e9n\u00e9, P. A., Scull, M. A., Idowu, T. O., Ogundaini, A. O., Meva'a, L. M., Abegaz, B. M., Rice, C. M., Andrae-Marobela, K., Brockman, M. A., Brumme, Z. L., & Fedida, D. (2015). Screening of the pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors. PLoS One, 10(4), 1-19. https://doi.org/10.1371/journal.pone.0121099"}, {"Citation": "UNESCO World heritage centre. (2012). Western Ghats. https://whc.unesco.org/en/list/1342/"}, {"Citation": "Van Rossum, T. G. J., Vulto, A. G., Hop, W. C. J., Brouwer, J. T., Niesters, H. G. M., & Schalm, S. W. (1999). Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial. Journal of Gastroenterology and Hepatology, 14(11), 1093-1099. https://doi.org/10.1046/j.1440-1746.1999.02008.x"}, {"Citation": "Wagoner, J., Morishima, C., Graf, T. N., Oberlies, N. H., Teissier, E., P\u00e9cheur, E.-L., Tavis, J. E., & Polyak, S. J. (2011). Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation. PLoS One, 6(1), 1-9. https://doi.org/10.1371/journal.pone.0016464"}, {"Citation": "Wagoner, J., Negash, A., Kane, O. J., Martinez, L. E., Nahmias, Y., Bourne, N., Owen, D. M., Grove, J., Brimacombe, C., McKeating, J. A., P\u00e9cheur, E.-I., Graf, T.-N., Oberlies, N. H., Lohmann, V., Cao, F., Tavis, J. E., & Polyak, S. J. (2010). Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology, 51(6), 1912-1921. https://doi.org/10.1002/hep.23587"}, {"Citation": "Wahyuni, T. S., Tumewu, L., Permanasari, A. A., Apriani, E., Adianti, M., Rahman, A., Widyawaruyanti, A., Lusida, M. I., Fuad, A., Soetjipto, N., Fuchino, H., Kawahara, N., Shoji, I., Deng, L., Aoki, C., & Hotta, H. (2013). Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus. Virology Journal, 10(259), 1-9."}, {"Citation": "Wahyuni, T. S., Widyawaruyanti, A., Lusida, M. I., Achmad Fuadb, S., Fuchino, H., Kawahara, N., Hayashi, Y., & Chie Aoki, H. H. (2014). Fitoterapia inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves. Fitoterapia, 99, 276-283. https://doi.org/10.1016/j.fitote.2014.10.011"}, {"Citation": "Wang, Y., Li, J., Wang, X., Pen\u00e3, J. C., Li, K., Zhang, T., & Ho, W. (2016). (\u2212)-Epigallocatechin-3-gallate enhances hepatitis C virus double-stranded RNA intermediates-triggered innate immune responses in hepatocytes. Scientific Reports, 6, 1-12. https://doi.org/10.1038/srep21595"}, {"Citation": "Widyawaruyanti, A., Tanjung, M., Permanasari, A. A., Saputri, R., Tumewu, L., Adianti, M., Utsubo, C. A., Hotta, H., Hafid, A. F., & Wahyuni, T. S. (2021). Alkaloid and benzopyran compounds of Melicope latifolia fruit exhibit anti-hepatitis C virus activities. BioMed Central Complementary Medicine and Therapies., 21, 1-9. https://doi.org/10.1186/s12906-021-03202-8"}, {"Citation": "Williamson, E. M., Liu, X., & Izzo, A. A. (2020). Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. British Journal of Pharmacology, 177(6), 1227-1240. https://doi.org/10.1111/bph.14943"}, {"Citation": "World Health Organization. (2022). Hepatitis C fact sheets. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c"}, {"Citation": "Wu, S.-F., Lin, C.-K., Chuang, Y.-S., Chang, F.-R., Tseng, C.-K., Wu, Y.-C., & Lee, J.-C. (2012). Anti-hepatitis C virus activity of 3-hydroxy caruilignan C from Swietenia macrophylla stems. Journal of Viral Hepatitis, 19(5), 364-370. https://doi.org/10.1111/j.1365-2893.2011.01558.x"}, {"Citation": "Xiao, F., Fofana, I., Thumann, C., Mailly, L., Alles, R., Robinet, E., Meyer, N., Schaeffer, M., Habersetzer, F., Doffo\u00ebl, M., Leyssen, P., Neyts, J., Zeisel, M. B., & Baumert, T. F. (2015). Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C. Gut, 64(3), 483-494. https://doi.org/10.1136/gutjnl-2013-306155"}, {"Citation": "Yang, X.-Y., Zhang, Y.-Y., Xie, W.-R., He, S. H., Wu, L.-H., He, X.-X., & Xia, H. H.-X. (2019). Herbal medicines for hepatitis C virus infection: The exploratory journey from bench to bedside still has a long way to go. Journal of Exploratory Research in Pharmacology, 4(2), 9-18. https://doi.org/10.14218/JERP.2019.00003"}, {"Citation": "Yang, Z., Zhuang, L., Lu, Y., Xu, Q., & Chen, X. (2014). Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: A meta-analysis of randomized controlled trials. BioMed Research International, 941085, 1-9. https://doi.org/10.1155/2014/941085"}, {"Citation": "Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., Ferenci, P., Nevens, F., M\u00fcllhaupt, B., Pockros, P., Terg, R., Shouval, D., Hoek, B. V., Weiland, O., Heeswijk, R. V., \u2026 REALIZE Study Team. (2011). Telaprevir for retreatment of HCV infection. The New England Journal of Medicine, 364(25), 2417-2428. https://doi.org/10.1056/NEJMoa1013086"}, {"Citation": "Zhang, H., Rothwangl, K., Mesecar, A. D., Sabahi, A., Rong, L., & Fong, H. H. S. (2009). Lamiridosins, hepatitis C virus entry inhibitors from Lamium album. Journal of Natural Products, 72(12), 2158-2162. https://doi.org/10.1021/np900549e"}, {"Citation": "Zhang, L., Wang, G., Hou, W., Li, P., Dulin, A., & Bonkovsky, H. L. (2010). Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review. Hepatology, 51(2), 690-698. https://doi.org/10.1002/hep.23384"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "6", "Day": "16"}, {"Year": "2023", "Month": "5", "Day": "16"}, {"Year": "2023", "Month": "6", "Day": "21"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "13", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "13", "Hour": "2", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37439007", "10.1002/ptr.7936"]}}], "PubmedBookArticle": []}